Bullfrog Ai Holdings Inc (BFRG) Stock Price, Quote & News

Company Profile

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment...

Industry: Health Information Services

Sector: Healthcare

Phone: 240 658 6710

Website: www.bullfrogai.com

Address:

325 Ellington Boulevard, Unit 317, Gaithersburg, United States

OTC85 Sep. 13 at 4:11 PM

$BCDS $AMC $GME $DVLT $BFRG

0 · Reply

OTC85 Sep. 11 at 10:00 PM

$BCDS $AMC $DVLT $BFRG $GPUS

0 · Reply

nueri Sep. 11 at 5:58 PM

$BFRG Wow!!! 0.46$

0 · Reply

iAccess_Alpha Sep. 11 at 1:24 PM

$BFRG presents next week at iAccess Alpha's Virtual Best Ideas Fall Investment Conference. September 15, 2026 | 2:00 PM ET Register to watch live: https://www.webcaster5.com/Webcast/Page/3171/54467 #microcap #smallcap #investing

0 · Reply

Newmoves Sep. 11 at 1:04 AM

$BFRG $TEM $RXRX AI seems to be everywhere now and has been all over the media recently. Why does it seem AI is going nowhere fast in healthcare? Hmm Big Pharma purposely slowing it down. You would think AI in healthcare would have taken off by now. Should be all the latest rage.

0 · Reply

OTC85 Sep. 10 at 5:53 PM

$BCDS $BFRG $CHUC $DFLI $EDGM

0 · Reply

rayzer202 Sep. 10 at 2:41 AM

$BFRG Vin mentioned the pilot would be closer to the 6 month side of things, we’re getting very close

0 · Reply

WeTheMarket Sep. 9 at 7:59 PM

$BFRG Posted today on Linkedin. BullFrog AI Posted 36m ago We're helping organizations strengthen data readiness and uncover meaningful insights through data prep and causal network analytics. Are you looking to accelerate your clinical impact, therapeutic pipelines, or reduce uncertainty when making operational decisions?

0 · Reply

WeTheMarket Sep. 9 at 7:57 PM

$BFRG Posted yesterday on BullFrog AI Linkedin page. Heading to the 9th Annual Neuropsychiatric Drug Development Summit in Boston, next week? So is Dr. Jamshid Arjomand, our Director of Neuroscience & Business Development. Spark ideas with a great person and seasoned industry colleague. Connect with him during the event to discuss how he’s helping biopharma and biotech with patient subgrouping projects and causal gene network analysis that grants access into one of the largest, clinically-annotated post-mortem brain tissue cohorts from LIBD. For your neuropsychiatric programs in MDD, SCZ, BP, and others, access data derived from data-rich biospecimens and couple that with our tech stack’s ability for deep interrogation into multiomic datasets.

0 · Reply

Newmoves Sep. 9 at 6:56 PM

$BFRG $TEM $RXRX make it or break it territory for this company. seems like they have legitimate AI technology. just one nice partnership deal with Big Pharma changes the whole dynamic to this company and could lead to even a possible buyout.

0 · Reply

BullFrog AI to Participate in September 2026 Investor Conferences

Jul 22, 2026, 4:15 PM EDT - 7 weeks ago

BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference

Jul 21, 2026, 4:15 PM EDT - 7 weeks ago

BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026

Jun 24, 2026, 1:00 PM EDT - 2 months ago

Water Tower Research Publishes Initiation of Coverage Report on BullFrog AI Holdings, Inc., "Helping Big Pharma Look Before It Leaps in Drug Discovery"

Jun 2, 2026, 8:00 AM EDT - 3 months ago

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

2026-05-29T20:40:11.000Z - 3 months ago

Bullfrog AI registers to sell 2M shares of common stock for holders

2026-04-22T12:20:47.000Z - 4 months ago

Bullfrog AI regains compliance with Nasdaq

Apr 22, 2026, 7:30 AM EDT - 4 months ago

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

Apr 14, 2026, 7:30 AM EDT - 5 months ago

BullFrog AI Announces Participation at AACR Annual Meeting

2026-04-13T13:44:13.000Z - 5 months ago

BullFrog AI issues shareholder letter highlighting recent progress, outlook

2026-04-13T13:29:17.000Z - 5 months ago

BullFrog AI issues shareholder letter highlighting recent progress, outlook

Apr 13, 2026, 7:30 AM EDT - 5 months ago

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

Mar 30, 2026, 4:55 PM EDT - 5 months ago

Bullfrog AI stock offers a rare opportunity for investors to take profit

2026-03-30T11:57:55.000Z - 5 months ago

Bullfrog AI enters commercial agreement with pharmaceutical company

Mar 30, 2026, 7:30 AM EDT - 5 months ago

BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder

Mar 25, 2026, 8:00 AM EDT - 5 months ago

BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

Mar 11, 2026, 8:00 AM EDT - 6 months ago

BullFrog to Host Webinar on New Precision AI Capability

2026-02-04T12:35:55.000Z - 7 months ago

Bullfrog AI to unveil new precision AI capability

Feb 4, 2026, 7:30 AM EST - 7 months ago

BullFrog AI to Unveil New Precision AI Capability

2026-01-27T12:40:13.000Z - 7 months ago

Bullfrog AI publishes whitepaper on data harmonization

2026-01-06T12:46:40.000Z - 8 months ago

Bullfrog AI highlights presentation of data from bfLEAP

Jan 6, 2026, 7:30 AM EST - 8 months ago

BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer

2025-12-30T13:36:00.000Z - 8 months ago

Bullfrog AI sees several developments as ‘important catalysts’ in 2026

2025-11-18T15:00:27.000Z - 9 months ago

Bullfrog AI publishes whitepaper on AI in Bioinformatics

2025-10-10T21:30:12.000Z - 11 months ago

Bullfrog AI files to sell 5M shares of common stock for holders

2025-09-30T12:25:15.000Z - 11 months ago

Bullfrog AI announces expansion of internal sales organization

2025-09-25T12:10:49.000Z - 11 months ago

Bullfrog AI, Sygnature announces official sales launch of BullFrog networks

2025-09-23T12:10:46.000Z - 11 months ago

Bullfrog AI to showcase AI-powered clinical data solutions in Xtalks Webinar

2025-09-08T12:15:17.000Z - 1 year ago

Bullfrog AI provides update on collaboration with Eleison

Sep 8, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI's bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration

Jul 28, 2025, 4:30 PM EDT - 1 year ago

BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference

2025-07-22T12:10:49.000Z - 1 year ago

Bullfrog AI announces white paper on smarter drug development

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development

2025-07-17T12:26:56.000Z - 1 year ago

Bullfrog AI launches bfPREP, an AI-powered data preparation module

2025-07-10T12:26:28.000Z - 1 year ago

Bullfrog AI unveils BullFrog Data Networks Solutions Library

2025-06-20T12:10:19.000Z - 1 year ago

Bullfrog AI ‘s Juan Felipe Beltran to be speaker at XTalks webinar

Jun 20, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

Jun 12, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

Dec 27, 2024, 8:00 AM EST - 1 year ago

BullFrog AI Issues Letter to Stockholders

Dec 17, 2024, 4:30 PM EST - 1 year ago

BullFrog AI Announces Appointment of Chief Financial Officer

Oct 22, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium

Oct 21, 2024, 1:00 PM EDT - 1 year ago

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 21, 2024, 11:45 AM EDT - 1 year ago

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 12:01 PM EDT - 1 year ago

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 9:30 AM EDT - 1 year ago

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 15, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

Oct 9, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Aug 26, 2024, 8:00 AM EDT - 2 years ago

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 25, 2024, 7:30 AM EDT - 2 years ago

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

May 29, 2024, 8:00 AM EDT - 2 years ago

Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12

May 16, 2024, 8:00 AM EDT - 2 years ago

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

Apr 26, 2024, 9:00 AM EDT - 2 years ago

BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Mar 8, 2024, 8:00 AM EST - 2 years ago

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

Feb 21, 2024, 12:01 PM EST - 2 years ago

BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock

Feb 9, 2024, 8:00 AM EST - 2 years ago

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

Feb 5, 2024, 10:15 AM EST - 2 years ago

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

Feb 5, 2024, 10:00 AM EST - 2 years ago

BullFrog AI Announces Closing of $5.7 Million Public Offering

Feb 1, 2024, 9:56 AM EST - 2 years ago

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

Feb 1, 2024, 9:00 AM EST - 2 years ago

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

Jan 26, 2024, 7:30 AM EST - 2 years ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Jan 17, 2024, 12:01 PM EST - 2 years ago

This AI stock is up 30% on Wednesday: find out more

Jan 17, 2024, 7:00 AM EST - 2 years ago

BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

Jan 16, 2024, 8:00 AM EST - 2 years ago

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Jan 11, 2024, 4:05 PM EST - 2 years ago

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

Dec 29, 2023, 8:00 AM EST - 2 years ago

BullFrog AI Issues Letter to Shareholders

Dec 6, 2023, 7:00 AM EST - 2 years ago

BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity

Oct 27, 2023, 9:00 AM EDT - 2 years ago

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ASPI

Oct 18, 2023, 9:00 AM EDT - 2 years ago

BullFrog AI to Present at Benzinga All Access Event on October 20

Oct 5, 2023, 8:00 AM EDT - 2 years ago

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

OTC85 Sep. 13 at 4:11 PM

$BCDS $AMC $GME $DVLT $BFRG

0 · Reply

OTC85 Sep. 11 at 10:00 PM

$BCDS $AMC $DVLT $BFRG $GPUS

0 · Reply

nueri Sep. 11 at 5:58 PM

$BFRG Wow!!! 0.46$

0 · Reply

iAccess_Alpha Sep. 11 at 1:24 PM

0 · Reply

Newmoves Sep. 11 at 1:04 AM

0 · Reply

OTC85 Sep. 10 at 5:53 PM

$BCDS $BFRG $CHUC $DFLI $EDGM

0 · Reply

rayzer202 Sep. 10 at 2:41 AM

$BFRG Vin mentioned the pilot would be closer to the 6 month side of things, we’re getting very close

0 · Reply

WeTheMarket Sep. 9 at 7:59 PM

0 · Reply

WeTheMarket Sep. 9 at 7:57 PM

0 · Reply

Newmoves Sep. 9 at 6:56 PM

0 · Reply

WeTheMarket Sep. 9 at 1:26 PM

$BFRG Meet the winning team. Cheers.

0 · Reply

WeTheMarket Sep. 9 at 10:07 AM

$BFRG https://ir.bullfrogai.com/news-events/press-releases/detail/89/bullfrog-ai-to-participate-in-september-2026-investor-conferences - iAccess Alpha Virtual Best Ideas Fall Investment Conference, being held September 15 & 16, 2026. BullFrog AI’s CEO Vin Singh will deliver a presentation at 2:00 PM ET on September 15th, available at this link https://www.webcaster5.com/Webcast/Page/3171/54467 This will be followed by one-on-one meetings with institutional investors on September 16th. - Water Tower Research Insights Conference, being held virtually September 22 & 23, 2026. James Kisner, Managing Director at Water Tower Research, will lead a fireside chat with BullFrog AI’s CEO Vin Singh at 1:00 PM ET on September 23rd. Investors and interested parties can access the fireside chat event by registering here https://event.webcasts.com/starthere.jsp?ei=1770861&tp_key=bfed48f4a8. A live webcast of these presentations can be accessed via the Investors section of BullFrog AI’s website at https://ir.bullfrogai.com/. A replay of both webcasts will be archived under the Company's News & Events page following the events.

0 · Reply

Bulltrader988 Sep. 8 at 8:36 PM

$BFRG "...iAccess Alpha Virtual Best Ideas Fall Investment Conference, being held September 15 & 16, 2026. BullFrog AI’s CEO Vin Singh will deliver a presentation at 2:00 PM ET on September 15th, available at this link. This will be followed by one-on-one meetings with institutional investors on September 16th... Water Tower Research Insights Conference, being held virtually September 22 & 23, 2026. James Kisner, Managing Director at Water Tower Research, will lead a fireside chat with BullFrog AI’s CEO Vin Singh at 1:00 PM ET on September 23rd. Investors and interested parties can access the fireside chat event by registering here..." 👃👀 https://www.stocktitan.net/news/BFRG/bull-frog-ai-to-participate-in-september-2026-investor-rur79d2yu9qy.html

0 · Reply

Newmoves Sep. 8 at 8:21 PM

$BFRG so over due for news here. Just one piece of positive news and this could easily double. Seems like something should come before end of year or sooner. Especially with all these new added positions and the fact that they doubled the size of their team. They are running mean and lean. Just need to strike a real deal. This tech has potential

1 · Reply

WeTheMarket Sep. 8 at 4:26 PM

$BFRG Posted earlier today on Linkedin.

0 · Reply

WeTheMarket Sep. 8 at 5:33 AM

$BFRG Now down to just two open positions. Source https://bullfrogai.com/careers/

0 · Reply

WeTheMarket Sep. 7 at 1:23 PM

$BFRG https://www.linkedin.com/company/bullfrogai/posts/?feedView=all https://bullfrogai.com/bfprep/#bfprepform

0 · Reply

OTC85 Sep. 5 at 6:28 PM

$BCDS $BFRG $VMAR $SPCE 💥

0 · Reply

rayzer202 Sep. 4 at 10:10 PM

$BFRG another job filled, only 2 left on careers page, good sign

0 · Reply

WeTheMarket Sep. 4 at 8:33 PM

$BFRG $CTM Nice close.

0 · Reply

OTC85 Sep. 4 at 6:52 PM

$BCDS $BFRG $DTREF $DVLT $GPUS

0 · Reply

Market Cap	8.82M
Revenue (ttm)	120,000.00
Net Income (ttm)	-6.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-5,416.67%
Debt to Equity Ratio	0.01

Volume	65,900
Avg Vol	124,876
Day's Range	N/A - N/A
Shares Out	18.54M
Stochastic %K	14%
Beta	-2.71
Analysts	Hold
Price Target	N/A